Bioinvent.
Swedish clinical-stage biotech company
- Reports this week
- 0
- Active events
- 0
- Connections
- 12
What's happening
Earlier this month
One to three months ago
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
Around Bioinvent this week
News at the entities that move Bioinvent most-
FDA StructuralBracco, based in Princeton, N.J., requires FDA approval for its products.Moves Bioinvent
-
Madrid Shared contextTeachers in Madrid are on strike over cuts to public education by the Community of Madrid.Moves Bioinvent
-
Sweden Shared contextSweden and Italy increased funding for democracy defenders on November 20, 2026.Moves Bioinvent
-
Congress Shared contextPentagon funding for the U.S.-Israel war on Iran is tied to Congressional budget decisions amid political pressure from Democrats and Republicans.Moves Bioinvent
Connections
The 11 strongest of 12, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
MSD Operational
MSD and Bioinvent are actively collaborating on a joint therapeutic effort, combining Bioinvent's antibody with MSD's anti-PD-1 therapy.
-
FDA Structural
The FDA granted Fast Track Designation to Bioinvent for its BI-1808 program.
-
Stefan Structural
Stefan Ericsson serves as the Chief Financial Officer of Bioinvent.
-
Merck KGaA Operational
Bioinvent is actively studying and combining its therapies with Merck KGaA's anti-PD-1 and KEYTRUDA® therapies.
-
Madrid Shared context
Madrid serves as the location for the ESMO Congress where Bioinvent presented data.
-
Abramson Cancer Center Operational
The entities are engaged in joint clinical research, evidenced by the presentation of Phase 2a trial data.
-
American Association for Cancer Research Mentioned together
Bioinvent published study results in the AACR journal.
-
European Society for Medical Oncology Operational
Bioinvent presented scientific data at the European Society for Medical Oncology Congress.
Show all 11 connections
-
Sweden Shared context
Bioinvent is headquartered in Lund, which is located within the borders of Sweden.
-
Lund Shared context
Bioinvent is geographically located in Lund, Sweden, where it conducts its operations and announcements.
-
Congress Shared context
Bioinvent presents research data at the Congress event.
History
Events by the month they beganOctober 2026
4 events- Bioinvent presented data combining its BI-1808 therapy with MSD's KEYTRUDA® at the ESMO Congress in Madrid.
- Bioinvent combined its antibody with MSD's anti-PD-1 therapy.
- Bioinvent published study results in the American Association for Cancer Research (AACR) journal.
- Stefan Ericsson serves as CFO of BioInvent as of October 12, 2026.